BMI View: Sweden is among the most attractive destinations for foreign investment within Europe. As one
of the most advanced economies in the world, the country benefits from an extremely developed
infrastructure network, a highly educated and competitive workforce, l ..."
BMI View: The expected growth of Sweden's ageing population over the next 50 years will have an
unprecedented impact on the demand for healthcare. The elderly require more medical check-ups and care
than young people as a result of the increased prevalence of chronic ..."
BMI View: In addition to a decline in the overall value of the Swedish pharmaceutical market in the
coming five years, we envisage the same trend in the number of clinical trials conducted in a country known
for its research capabilities. As the costs of pharmaceutica ..."
BMI View: We remain of the opinion that the value of the Swedish pharmaceutical market will decline in US dollars over our five-year forecast period to 2017, partly on account of deteriorating external economic environment, with stagnation on the cards in local currency terms. Wh ..."
We remain of the opinion that Sweden's overall pharmaceutical market value will decline over the forecast period to 2016, both in local currency and US dollar terms. We base our view on patent expiration and cost containment policies , which will continue to stimulate consumption ..."
BMI View: Our five-year forecasts for the Swedish pharmaceutical market show a decline in its overall size, which is expected to fall to SEK42.02bn (US$5.64bn) by 2016. Key reasons for this pessimism include patent expirations and the subsequent entry of copy products, coupled wi ..."